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Abstract 
Objective 
Around 30%-50% of patients with depression and anxiety disorders fail to respond to standard 
psychological therapy. Given that cortisol affects cognition, patients with altered hypothalamic-pituitary-
adrenal (HPA) axis functioning may benefit less from such treatments. To investigate this, reliable pre-
treatment cortisol measures are needed. 
Method 
N=89 outpatients with depression and anxiety disorders were recruited before undergoing therapy within 
an Improving Access to Psychological Therapies (IAPT) service. Three-months hair cortisol was 
determined and the Childhood Trauma Questionnaire was administered. Patients were classified as 
responders if they showed significant decreases in depression (>= 6 points on the Patient Health 
Questionnaire) or anxiety (>= 5 points on the Generalised Anxiety Disorder Scale). 
Results 
Non-responders in terms of depression (57%) had lower pre-treatment hair cortisol concentrations 
(p=.041) and reported more physical abuse (p=.024), sexual abuse (p=.010), and total trauma (p=.039) 
when compared to responders. Non-responders in terms of anxiety (48%) had lower pre-treatment hair 
cortisol (p=.027), as well as higher levels of emotional abuse (p=.034), physical abuse (p=.042), and 
total trauma (p=.048). 
Conclusion 
If future research confirms hair cortisol and childhood trauma to be predictors of psychological therapy 
response, this may prove a useful clinical biomarker which identifies a subgroup requiring more intensive 
treatments. 
 
Keywords: anxiety disorders; childhood trauma; depression; hair cortisol; psychological therapy 
 
Significant outcomes: 
This is the first study to show that pre-treatment hair cortisol can predict psychological therapy outcomes 
in patients with depression and anxiety disorders. 
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Limitations: 
Half of the initial sample was lost due to patients’ inability to provide hair samples. 
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Introduction 
Psychological therapy is one of the most effective treatments for depression and anxiety disorders (1, 
2). In terms of depression, the most important interventions are behavioural activation and cognitive 
restructuring, while relaxation training and exposure to threat cues are key modules of standard first-
line therapies for anxiety disorders. Given the high comorbidity between depression and anxiety (e.g., 
3), these elements are often combined to provide treatments that are tailored to the needs of the 
individual patient. However, despite the general efficacy of such approaches, around 30% of patients 
with anxiety disorders (4) and 50% of patients with depression (1) do not respond sufficiently to 
psychological therapy. This raises the question of which factors may predict non-responses. 
A number of studies have identified illness chronicity, severity, and comorbidity with other mental 
disorders as the most promising candidates to predict non-responses (4, 5). More recently, biological 
markers reflecting specific pathophysiological alterations have attracted researchers’ attention (e.g., 6). 
The glucocorticoid cortisol, the main end product of the stress-responsive hypothalamic-pituitary-
adrenal (HPA) axis, was among the first biomarkers to be tested as a predictor of treatment outcomes. 
As evident from recent systematic reviews and meta-analyses, depressed patients retaining relatively 
high levels of cortisol when probed with dexamethasone (a synthetic glucocorticoid) seem less likely to 
respond to psychological therapy when compared to those with relatively low levels (7). In patients with 
anxiety disorders, the majority of studies find lower levels during exposure sessions predictive of non-
responsiveness (8). These findings are intriguing in light of the evidence linking cortisol with cognition 
(9, 10), and may implicate that patients with alterations in pre-treatment HPA axis functioning are less 
likely to profit from treatments relying on cognitive processes, such as psychological therapy. 
Interestingly, while both of the above syntheses of the literature found evidence for post-
challenge cortisol concentrations to predict responses to psychological therapy, the evidence in terms 
of resting cortisol was far less consistent. One explanation for this discrepancy is that post-challenge 
values require repeated sampling schedules, and as such provide more reliable estimates of pre-
treatment HPA axis functioning than single time point measures, which are often used for resting cortisol. 
Indeed, only studies using cumulative measures of resting cortisol, such as 24h urine samples (11, 12) 
or repeated saliva sampling over the course of at least one day (13, 14) seem to be able to demonstrate 
a link with treatment outcomes. By contrast, studies using one-off morning blood samples (15) or saliva 
samples immediately before a therapy session (16) were unable to yield positive findings, which may 
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have also been also due to anticipatory stress linked with venepuncture or treatment. Clearly, studies 
employing reliable and valid measures of resting cortisol are warranted to further disentangle the role of 
cortisol in the non-response to psychological therapy phenomenon. 
The main aim of the present study was to investigate for the first time whether hair cortisol 
concentrations representing the three months preceding psychological therapy could predict outcomes 
in a mixed sample of patients with depression and anxiety disorders. Hair bears several advantages 
over traditional specimens to determine cortisol: it is economical in that repeated sampling can be 
avoided, non-invasive, and - in covering a period of several weeks - is less susceptible to the influence 
of state-like confounders (e.g., anticipatory stress; 17, 18). Based on prior evidence of attenuated hair 
cortisol in patients with comorbid major depressive disorder (MDD) and generalised anxiety disorder 
(GAD; 19, 20), it was expected that non-responders to psychological therapy would be characterised by 
lower hair cortisol concentrations when compared to responders. In addition, the study aimed to explore 
the role of childhood trauma, which not only has been found an important predictor of non-response in 
depression (see 21 for a meta-analysis), but appears to have direct links with hair cortisol in patients 
with MDD (22, 23). 
 
Methods 
Sample and protocol 
This study was part of a larger project on predictors of outcomes following psychological therapy 
(PROMPT). Details on the general procedures can be found in the published study protocol (24). The 
project used a naturalistic observational design. All patients referred to the Improving Access to 
Psychological Therapies (IAPT) service in the London borough of Southwark from 30th January, 2014 
to 30th July 2016 were contacted. The service represents a national initiative that aims at reducing both 
mild to severe depression and anxiety by widespread deliverance of evidence-based psychological 
therapy (25). Individuals interested in participating in the study were scheduled for an appointment at 
the NIHR/Wellcome Trust King’s Clinical Research Facility. For the present study, inclusionary criteria 
were fluency in English, hair length of at least 3cm, and having any of the following depressive or anxiety 
disorders: MDD, dysthymia, bipolar disorder, panic disorder, agoraphobia, specific phobia, social 
anxiety disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), or GAD. 
In addition, patients had to complete at least one session of IAPT therapy. Exclusionary criteria were 
intake of corticosteroids, alcohol and substance abuse or dependence, psychotic disorders, and 
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anorexia nervosa. After obtaining written informed consent, a standardised clinical assessment was 
conducted to establish diagnoses of mental disorders, and questionnaires assessing sociodemographic 
variables, current medication, and childhood trauma were administered (see below). Hair samples were 
collected at the end of the appointment. Treatment at the IAPT service included all therapeutic 
approaches for mild to moderate depressive and anxiety disorders as recommended by NICE guidelines 
(see also 26). Patients received Step 2 versus Step 3 treatment according to the severity of their 
symptoms. Step 2 therapies are low intensity treatments usually of up to six sessions, and include 
guided self-help, computerised cognitive behavioural therapy (CBT) and various group therapies such 
as psychoeducation, behavioural activation, and mindfulness. Step 3 therapies are high intensity 
treatments usually of longer duration, and predominantly consist of CBT, but also include counselling 
and interpersonal psychotherapy. Measures of depressive symptoms and anxiety are taken routinely in 
the IAPT service; for the present study we extracted from the IPAT database the scores obtained at the 
pre-treatment initial assessment and during the final IAPT therapy session. The final sample size of this 
study was N=89. This study was approved by the Bromley NHS Research Ethics Committee (Ref.: 
13/LO/1347). 
 
Psychological measures 
Depression and anxiety disorders were diagnosed by means of the Mini-International Neuropsychiatric 
Interview (MINI; 27). The MINI captures (recurrent) MDD, dysthymia, manic and hypomanic episodes, 
panic disorder, agoraphobia, social phobia, OCD, PTSD, alcohol abuse and dependence, substance 
use and dependence, psychotic disorders, anorexia nervosa, bulimia nervosa, GAD, and antisocial 
personality disorder in accordance with DSM-IV-TR criteria (28). Borderline personality disorder was 
diagnosed via the Structured Clinical Interview for DSM Personality Disorders (SCID-II; 29). All 
interviewers had a degree in psychology and were extensively trained in conducting clinical interviews 
by a psychiatrist (AJC) with regular standardisation sessions during the study. 
The Childhood Trauma Questionnaire (CTQ; 30) was administered to measure childhood abuse 
and neglect. The CTQ distinguishes five trauma domains: emotional abuse, physical abuse, sexual 
abuse, emotional neglect, and physical neglect, each measured by five items. For the present study, 
subscale sum scores and a total score were calculated and individuals were categorised as with vs. 
without trauma based on validated moderate to severe cut-off scores (31). 
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Depression severity was measured by the depression module of the Patient Health Questionnaire 
(PHQ-9; 32). Nine items based on DSM-IV-TR criteria are rated on a four-point Likert scale from 0 (“not 
at all”) to 3 (“nearly every day”). Scores above five (out of 27) indicate mild levels of depression, scores 
above ten moderate levels, and scores from 15 onwards severe levels of depression. The PHQ-9 was 
administered twice: at the beginning of IAPT therapy and at the end. The validity of the PHQ-9 as a 
measure of symptom severity has been demonstrated in numerous studies (e.g., 32). A Reliable Change 
Index (RCI) was calculated, according to which patients were considered treatment responders in terms 
of depression if they displayed a decrease of at least six points on the PHQ-9 (33).  
Anxiety severity was measured by means of the Generalised Anxiety Disorder Scale (GAD-7; 34). 
The GAD-7 consists of seven items based on the DSM-IV-TR criteria for GAD, but the scale is commonly 
used as a general measure of anxiety. The answering scale ranges from 0 (“not at all”) to 3 (“nearly 
every day”). Scores above five correspond to mild levels of anxiety, scores above ten represent 
moderate levels, and scores from 15 onwards indicate severe anxiety. Evidence for the validity of the 
GAD-7 as a means to assess symptom severity has been provided by numerous studies (e.g., 34). 
Patients were categorised as treatment responders in terms of anxiety if their GAD-7 scores had 
decreased by at least five points at the end of their IAPT treatment (33).  
 
Biological measures 
Two to three clusters of hair were collected from as close to the scalp as possible and cut into 3cm 
segments, reflecting a three-month retrospective period. All samples were washed twice with 2mL 
isopropanol and dried at room temperature for 24h. The hair was then pulverised with a ball mill and 10-
15mg were incubated with 1.5mL of methanol for 1 hour in order to extract cortisol. The methanol was 
removed at 60°C under a gentle stream of nitrogen and the residue was reconstituted in 1mL of 
phosphate buffer. Cortisol concentrations were determined using the Immulite Immunoassay analyser 
(www.diagnostics.siemens.com) as described previously (35). The inter- and intra-assay variance of 
this assay is below 10%. 
 
Statistical analysis 
Data were checked for normal distribution and hair cortisol concentrations were log-transformed as a 
result of this. First, non-responders and responders were compared in terms of pre-treatment symptom 
severity, pre-treatment degree of comorbidity, and variables related to treatment. Mann-Whitney U tests 
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and Chi-squared tests were used to test this. Pre-treatment symptom severity, type of treatment, and 
number of treatment sessions were accounted for in all statistical models comparing non-responders 
and responders. Previously identified confounders of hair cortisol, namely age, BMI, the season 
reflected in the hair sample, heat-based treatments (e.g., curling irons), intake of hormonal 
contraceptives, antidepressants, and painkillers (36) were included in all models with hair cortisol as the 
dependent variable. Second, univariate ANOVAs were conducted to compare non-responders and 
responders regarding a) pre-treatment hair cortisol concentrations, and b) childhood trauma. This was 
to answer the main research question of this study, namely whether hair cortisol and childhood trauma 
predict treatment outcomes. Third, patients with vs. without childhood trauma were compared in terms 
of hair cortisol, again using univariate ANOVAs. The purpose of this was to investigate whether hair 
cortisol concentrations were related to experiences of childhood trauma. Finally, explorative analyses 
were undertaken to examine whether hair cortisol moderated any potential effect of childhood trauma 
on treatment outcomes. Binary logistic regression analyses were used for this. All analyses were 
performed in SPSS 22 and the alpha error was set at 5%. 
 
Results 
Patient characteristics 
Patient characteristics are presented in Table 1. Nearly the entire sample was female, which most likely 
was due to a combination of the general female preponderance of depression and anxiety disorders 
and their increased ability to provide hair samples (47% of the total sample had been unable and 3% 
had been unwilling to give hair). Patients were in their mid-thirties and slightly overweight on average. 
The most frequent diagnosis was GAD, followed by MDD and agoraphobia. Comorbidity was high, with 
52% of patients fulfilling criteria for both a depressive and an anxiety disorder. A little less than half of 
the patients were on antidepressants, while almost no other psychotropic medication was used. The 
median pre-treatment depression score was 14 (9.5), corresponding to a moderate level of depression. 
The median anxiety score was 12 (8.5), which meant that the sample presented with moderate anxiety 
before treatment. The median number of treatment sessions was 11 (9) and the median time between 
the first and the final treatment sessions was 6 (7) months. Low intensity group therapies (46%), and 
high intensity CBT (17%) and counselling (17%) were the most frequent types of IAPT therapies patients 
received. The overall response rates were 43% regarding depression (overall median post-treatment 
score: 8 (8)) and 52% regarding anxiety (overall median post-treatment score: 7 (7)). 
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Non-responders and responders did not differ in the number of pre-treatment diagnoses of mental 
disorders, nor in their intake of antidepressants, IAPT treatment duration, number of treatment sessions, 
and type of therapy received (all p>.147). Non-responders did, however, have lower pre-treatment levels 
of depression (U=-4.67, p<.001) and anxiety (U=-3.94, p<.001) when compared to responders. 
Symptom severity, type of treatment, and number of treatment sessions, and confounders of hair cortisol 
were included as predictors in all subsequent statistical models. 
 
Hair cortisol as predictor of treatment response 
Median hair cortisol concentrations were 153 (321.2) pg/mg. Controlling for pre-treatment levels of 
depression, type of treatment, number of treatment sessions, and confounders of hair cortisol, non-
responders in terms of depression had significantly lower pre-treatment hair cortisol when compared to 
responders (131.9 (214.1) pg/mg vs. 153 (409) pg/mg, F(1, 60)=4.371, p=.041, eta2=.068). Likewise, 
non-responders in terms of anxiety had lower pre-treatment cortisol concentrations when compared to 
responders (131.9 (214.1) pg/mg vs. 150.6 (245) pg/mg, F(1, 60)=4.965, p=.027, eta2=.079). 
 
Childhood trauma as predictor of treatment response 
The prevalence of childhood trauma was 24% for emotional abuse, 21% for emotional neglect, 19% for 
sexual abuse, 17% for physical neglect, 6% for physical abuse, and 24% for any type of childhood 
trauma. Controlling for pre-treatment levels of depression, type of treatment, and number of treatment 
sessions, non-responders in terms of depression had higher levels of physical abuse (F(1, 67)=5.306, 
p=.024, eta2=.073), sexual abuse (F(1, 67)=6.971, p=.010, eta2=.094), and childhood trauma in general 
(F(1, 67)=4.412, p=.039; eta2=.062; see also Figures 1A and 1B). Similarly, controlling for pre-treatment 
levels of anxiety, type of treatment, and number of treatment sessions, non-responders in terms of 
anxiety reported more emotional abuse (F(1, 67)=4.711, p=.034, eta2=.066), physical abuse (F(1, 
67)=4.281, p=.042, eta2=.060), and childhood trauma in general (F(1, 67)=4.061, p=.048, eta2=.057; 
see also Figures 2A and 2B). 
 
-Insert Figures 1A and 1B and 2A and 2B here- 
 
Hair cortisol in relation to childhood trauma 
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Controlling for confounders of hair cortisol, there were no differences in hair cortisol concentrations when 
comparing patients without vs. with childhood abuse and neglect (emotional abuse: 152.5 (396.5) pg/mg 
vs. 150.9 (156.2) pg/mg, F(1, 72)=1.073, p=.304, eta2=.015; physical abuse: 153 (289.8) pg/mg vs. 54.5 
(137.8) pg/mg, F(1, 72)=1.646, p=.204, eta2=.022; sexual abuse: 152.1 (338.2) pg/mg vs. 146.8 (179.4) 
pg/mg, F(1, 72)=0.303, p=.584, eta2=.004; emotional neglect: 149 (257) pg/mg vs. 152.1 (237.2) pg/mg, 
F(1, 72)=0.004, p=.950, eta2=.000; physical neglect: 160.6 (305.7) pg/mg vs. 132.4 (130.7) pg/mg, F(1, 
72)=1.263, p=.265, eta2=.017; total score: 152.5 (396.5) pg/mg vs. 150.9 (156.2) pg/mg, F(1, 72)=1.073, 
p=.304, eta2=.015). 
Exploratory analyses revealed that hair cortisol neither moderated the observed effects of 
childhood trauma on treatment response in terms of depression (interaction term emotional abuse: 
OR=0.987 (0.881-1.106), p=.820; physical abuse: OR=1.056 (0.635-1.756), p=.843; sexual abuse: 
OR=1.094 (0.750-1.596), p=.640; emotional neglect: OR=1.069 (0.956-1.194), p=.242; physical neglect: 
OR=1.062 (0.851-1.326), p=.596; total score: OR=1.012 (0.970-1.055), p=.581), nor in terms of anxiety 
(interaction term emotional abuse: OR=1.067 (0.933-1.221), p=.344; physical abuse: OR=1.019 (0.607-
1.709), p=.944; sexual abuse: OR=1.140 (0.829-1.569), p=.421; emotional neglect: OR=1.134 (0.999-
1.288), p=.052; physical neglect: OR=1.131 (0.886-1.443), p=.323; total score: OR=1.039 (0.987-
1.093), p=.143). 
 
Discussion 
The present study yielded two findings. First, in this mixed sample of patients with depression and 
anxiety disorders, those who were later classified as non-responders to psychological therapy had lower 
hair cortisol concentrations when compared to responders. Second, patients reporting childhood trauma 
were more likely to be non-responders. However, childhood trauma was found unrelated to hair cortisol 
suggesting that these are independent predictors of non-responses. 
This is the first study using hair cortisol as a predictor of response to standard first-line 
treatments (i.e., psychological therapy, antidepressants). In addition, only a handful of studies have 
investigated cortisol as a predictor of response to psychological therapy. In depression, a recent meta-
analysis yielded a trend for higher resting cortisol to predict more depressive symptoms upon completion 
of psychological therapy (7), while no such associations were found in anxiety disorders (8). However, 
all studies employing cumulative (i.e., 24h urine) or repeated measures of cortisol (i.e., saliva sampling 
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over the course of the day) were able to demonstrate a link between higher pre-treatment cortisol levels 
and outcomes, while those using one-off measures (most of which were confounded by venepuncture 
or anticipation of therapy sessions on the same day) yielded null-findings. Supporting this notion, 
another meta-analysis large enough to also allow meta-regression showed that only studies determining 
cortisol in urine and saliva were able to find links with antidepressant treatment response (37). When 
taken together, the current state of the literature suggests that resting cortisol is able to predict 
responses to psychological therapy, albeit only when measured in a reliable and valid way (i.e., using 
hair, 24 h urine, or repeated saliva sampling). 
The studies employing such measures found higher rather than lower cortisol concentrations 
predicted non-responses to psychological therapy (11-14). This appears to stand in contrast to the 
findings of the present study. One explanation for this discrepancy is that hair cortisol reflects long-term 
(e.g., three months) rather than short-term (12h or 24h) cortisol secretion (17, 18). Indeed, hair, saliva, 
and urinary cortisol are significantly correlated only when the latter two measures are repeatedly 
measured and integrated to cover the same period that is reflected in the hair sample (e.g., one month; 
38). This means that while all three measures are valid indicators of HPA axis activity, they differ in the 
time frame covered. Further studies in patient populations are warranted to determine which 
specimen/time frames are best chosen to distinguish patients from healthy controls (e.g., 39), 
characterise subtypes of a particular disorder (e.g., depression; 40), or predict treatment responses. A 
second explanation lies in sample characteristics: while previous studies were confined to either 
depressed or anxious patients, ours was a mixed sample of patients with depression and anxiety 
disorders (52% comorbidity), as typically encountered in clinical and population studies as well as in 
IAPT services (26). Considering the high degree of comorbidity, our finding is consistent with previous 
evidence of attenuated hair cortisol in patients fulfilling diagnostic criteria for both MDD and GAD (19, 
20) and could be interpreted as showing that patients with more severe pre-treatment alterations of the 
HPA axis are less likely to respond to standard psychological therapy. The finding is also interesting in 
light of evidence linking cortisol with fear extinction, a pivotal cognitive process in the psychological 
treatment of anxiety disorders, such as GAD (10). More specifically, there is evidence to suggest that 
increases in cortisol during exposure therapy sessions are beneficial in impeding the retrieval of the fear 
memory while at the same time facilitating the consolidation of the extinction memory. In line with this, 
a recent systematic review showed that lower cortisol concentrations during exposure therapy sessions 
was linked with worse treatment responses (8). It is thus possible that the lowered HCC in non-
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responders in the present study is paralleled by a failure to mount sufficient cortisol responses over the 
course of treatment. Mechanistic studies are now warranted to examine to what extent pre-treatment 
alterations of the HPA axis interfere with specific psychological interventions, such as exposure to threat 
cues. 
Our second finding of childhood trauma predicting non-responses is in agreement with a meta-
analysis showing that depressed patients with childhood trauma are more likely to be non-responders 
to standard first-line treatments (21). Our study shows that this appears to extend to mixed samples of 
patients with both depression and anxiety disorders undergoing treatment via IAPT services (26). In the 
above meta-analysis, childhood trauma was not only found a predictor of non-response to treatment, 
but also of protracted illness trajectories (i.e., recurrent or persistent forms of depression; 21). From a 
clinical perspective, both findings fit in well with the notion of a particular subgroup of depressed patients 
characterised by severe interpersonal difficulties, which are rooted in early maladaptive caregiving and 
may require specific psychological therapy that goes beyond what is offered by standard IPT or CBT 
(e.g., 41). 
Not only may childhood trauma result in interpersonal difficulties, but traumatised patients have 
repeatedly been shown to exhibit distinct biological signatures (e.g., 42). An extensive literature has 
documented the effects of childhood trauma on HPA axis functioning (e.g., 43, 44-46). In terms of hair 
cortisol, both Hinkelmann et al. (23) and Duncko, Fischer (22) found attenuated levels in depressed 
patients with versus without childhood trauma. It is noteworthy that childhood trauma was found 
unrelated to hair cortisol concentrations in the current sample, but again, the diagnostic heterogeneity 
of the present sample renders a comparison with the two previous studies difficult and further studies 
are required to investigate this issue in greater detail. Ideally, such studies would be large enough to 
also allow for a stratification of the sample according to the severity of childhood trauma, which may be 
followed by different alterations of the HPA axis. For instance, while Heim, Newport (47) found increased 
cortisol responses to acute stress in depressed women with severe childhood abuse, Carpenter, 
Carvalho (48) found an opposite pattern in healthy women exposed to less severe maltreatment during 
childhood. A crucial mechanism by which such alterations occurs is via DNA methylation within genes 
encoding different HPA axis components (e.g., NR3C1; 49). More specifically, it is assumed that 
parental behaviour towards offspring shapes phenotypes to match the early life environment, such as 
that both increased and decreased HPA axis reactivity may be considered adaptive, depending on the 
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amount of early life stress present. Boyce and Ellis (50) have argued that both low and high levels of 
early life stress favour the development higher biological sensitivity to context. Following from this, it is 
intriguing to speculate that highly reactive or sensitive individuals may also be more responsive to the 
effects of psychological therapy (see also 51). Large trials integrating measures of a patients’ genetic 
and epigenetic make-up with in-depth accounts of their early life environment are necessary to test 
these hypotheses systematically. 
This study offers a number of strengths, such as it being the first to use hair cortisol as a predictor 
of psychological therapy outcomes. Hair cortisol is a reliable and valid indicator of long-term HPA axis 
activity and bears several advantages when compared to conventional methodologies, including its non-
invasiveness and the possibility to avoid repeated sampling. This also renders hair cortisol an interesting 
candidate when conceiving of ways to translate the findings of this research into clinical practice. 
Another strength of our study is its high ecological validity, which results from recruiting patients via an 
IAPT service rather than within a clinical trial. Finally, this was the first study to use both cortisol and 
childhood trauma as predictors of psychological therapy response, and we believe that the combination 
of biological and psychological markers has greater potential in characterising a subgroup of patients 
who are non-responsive to standard first-line treatments. A number of limitations equally deserve 
mentioning. First, hair sampling requires that participants are both willing and able to give hair, and 50% 
of patients had to be excluded from our study for this reason. This not only reduced our sample size, 
but also affected the composition of the present sample, which was largely women, hence limiting the 
generalisability of our findings. Second, for economic reasons, we relied on short, self-reported outcome 
measures, while it would have been preferable to use more in-depth questionnaires or interviews. Third, 
the downside of high ecological validity is low internal validity. Recruiting from an IAPT service, we were 
unable to determine which intervention modules in particular may have been affected by patients’ HPA 
functioning. Finally, no post-treatment measures of cortisol were obtained, which arguably would have 
been informative in terms of the mechanisms underlying successful therapies. 
In sum, the present study demonstrates that both pre-treatment hair cortisol and the degree of 
childhood trauma are able to predict whether depressed and/or anxious patients go on to respond to 
standard psychological therapy. Further research is required to replicate this finding and determine why 
HPA axis functioning might be instrumental to successful psychological therapy. More specifically, it 
should be tested to what extent particular interventions inherent in evidence-based treatments for 
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depression and anxiety are affected by pre-treatment alterations in the HPA axis (e.g., cognitive 
restructuring). In addition, large-scale studies allowing to stratify patients according to the presence of 
childhood trauma and diagnostic (sub-)categories are warranted to examine whether HPA alterations 
are indicative of a particular subgroup of patients. It is our hope that this research will ultimately result 
in more effective application of current standard first-line therapies and the development of additional or 
alternative options for those in need of more specific treatment. 
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Table legends 
Table 1 Pre-treatment patient characteristics of patients with depression and anxiety disorders (N=89). 
Descriptives are given as median and interquartile range or frequencies. 
  
 23 
Figure legends 
Figures 1A and 1B Childhood trauma scores (total score and subscales) in non-responders vs. 
responders to psychological therapy. Results are shown for responses in terms of depression (PHQ-9). 
Bars represent means and standard errors. 
Figures 2A and 2B Childhood trauma scores (total score and subscales) in non-responders vs. 
responders to psychological therapy. Results are shown for responses in terms of anxiety (GAD-7). Bars 
represent means and standard errors. 
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Table 1 Pre-treatment patient characteristics of patients with depression and anxiety disorders (N=89). 
Descriptives are given as median and interquartile range or frequencies. 
 Descriptive 
Age (years) 34 (20.5) 
Sex  
Female 83 (93%) 
Male 6 (7%) 
Body Mass Index (BMI; kg/m2) 24.4 (10.1) 
Diagnoses (MINI and SCID-II)  
Agoraphobia 33 (38%) 
Antisocial personality disorder 2 (2%) 
Borderline personality disorder 8 (9%) 
Dysthymia 7 (8%) 
Generalised anxiety disorder 54 (61%) 
Hypomanic episode  
Current 6 (7%) 
Past 16 (18%) 
Major depressive disorder  
Current 37 (42%) 
Recurrent 31 (36%) 
Manic episode  
Current 2 (2%) 
Past 5 (6%) 
Obsessive-compulsive disorder 17 (19%) 
Panic disorder 18 (21%) 
Post-traumatic stress disorder 11 (12%) 
Social anxiety disorder 29 (33%) 
Medication  
 25 
Antidepressants 38 (43%) 
Antipsychotics 0 (0%) 
Benzodiazepines 2 (2%) 
Mood stabilisers 0 (0%) 
Thyroid hormones 4 (5%) 
MINI = Mini-International Neuropsychiatric Interview 
SCID-II = Structured Clinical Interview for DSM-IV Personality Disorders 
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Figures 1A and 1B Childhood trauma scores (total score and subscales) in non-responders vs. 
responders to psychological therapy. Results are shown for responses in terms of depression (PHQ-9). 
Bars represent means and standard errors. 
 
*p<.05 
CTQ = Childhood trauma questionnaire 
EA = Emotional abuse 
EN = Emotional neglect 
PA = Physical abuse 
PHQ-9 = Depression module of the Patient Health Questionnaire 
PN = Physical neglect 
SA = Sexual abuse 
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Figures 2A and 2B Childhood trauma scores (total score and subscales) in non-responders vs. 
responders to psychological therapy. Results are shown for responses in terms of anxiety (GAD-7). Bars 
represent means and standard errors. 
 
*p<.05 
CTQ = Childhood trauma questionnaire 
EA = Emotional abuse 
EN = Emotional neglect 
GAD-7 = Generalised Anxiety Disorder Scale 
PA = Physical abuse 
PN = Physical neglect 
SA = Sexual abuse 
